Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 20-F, Date: 2018-08-10, XBRL Interactive Financials
Original SEC Filing: Click here
Webplus: KANG/20180810/20-F/1/000.htm SEC Original: a18-17215_120f.htm
* Not for trading, but only in connection with the listing on The NASDAQ Global Select Market of American depositary shares. Currently, two ADSs represent one Class A common shares. None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of
Webplus: KANG/20180810/20-F/2_EX-4.47/000.htm SEC Original: a18-17215_1ex4d47.htm
Strictly Confidential Supplemental Agreement II to the Loan Agreement This Supplemental Agreement II to the Loan Agreement (hereinafter referred to as the Supplemental Agreement II) is entered into by the following Parties in accordance with relevant Chinese laws, regulations and rules on July 10, 2017 in the Peoples Republic of China (hereinafter referred to as China): Borrower: iKang Health Technology
Webplus: KANG/20180810/20-F/3_EX-4.48/000.htm SEC Original: a18-17215_1ex4d48.htm
No.: [XYZG[2017]-H20170009-HHXY] Limited Partnership Agreement of Aiying Xingsheng Medical Equity Investment Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Executed in [Pudong New Area, Shanghai] [October] 2017 Table of Contents Article 1 Definitions 5 1.1 Definitions 5 Article 2 Establishment of the Limited Partnership 9 2.1 Basis for Establishment 9 2.2 Name of the Limited Partnership 9 2.3 Main
Webplus: KANG/20180810/20-F/4_EX-4.49/000.htm SEC Original: a18-17215_1ex4d49.htm
Strictly Confidential Supplemental Agreement to the Investment Agreement This Supplemental Agreement to the Investment Agreement (the Supplemental Agreement) was entered into by the following parties in accordance with relevant Chinese laws, regulations and rules on December 13, 2017: Investor: Investee: Whereas: 1. Zhongjin Zhide Equity Investment Management Co., Ltd. (Zhongjin Zhide) and the Investee signed the Investment Agreement (Investment Agreement)
Webplus: KANG/20180810/20-F/5_EX-4.50/000.htm SEC Original: a18-17215_1ex4d50.htm
(Limited Partnership) Agreement of Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area AVICTC2017X0652-1 December 2017 Table of Contents Article 1 Establishment of Limited Partnership 5 1.1 Establishment Basis 5 1.2 Name of Limited Partnership 5 1.3 Main Business Premises 5 1.4 Partnership Purpose and Business Scope 6 1.5 Partners 6 1.6 Duration of the Partnership 7
Webplus: KANG/20180810/20-F/6_EX-4.51/000.htm SEC Original: a18-17215_1ex4d51.htm
Forward Share Purchase Agreement Forward Share Purchase Agreement AVICTC2017X0652-3 Contract No.: Seller: Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Buyer: iKang Guobin Medical Examination Management Co., Ltd. Forward Share Purchase Agreement Seller: Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Managing Partner: Ligang Capital Investment (Shenzhen) Co., Ltd. Representative of the
Webplus: KANG/20180810/20-F/7_EX-4.52/000.htm SEC Original: a18-17215_1ex4d52.htm
Letter of Authorization for Management Rights Principal: Hangkang Investment Management Partnership (Limited Partnership) of Ningbo Meishan Bonded Port Area Uniform Social Credit Code: 91330206MA2AF7HM97 Agent: iKang Guobin Medical Examination Management Co., Ltd. Uniform Social Credit Code: 911100007667680727 Whereas, 1. 2. 1. Scope of Authorization The Principal hereby irrevocably undertakes to fully delegate its management rights in the Company to the
Webplus: KANG/20180810/20-F/8_EX-4.53/000.htm SEC Original: a18-17215_1ex4d53.htm
Agreement Extension Notice To: iKang Health Technology Group Co., Ltd., Mr. Boquan He and Mr. Lee Ligang Zhang Date of Notification: March 22, 2018 iKang Technology Company March 17, 2008 March 17, 2008 March 16, 2018 Whereas iKang Health Technology Group Co., Ltd. (formerly known as Shanghai Guobin Medical Holding Co., Ltd., hereinafter referred to as ten (10) March
Webplus: KANG/20180810/20-F/9_EX-4.54/000.htm SEC Original: a18-17215_1ex4d54.htm
Supplemental Agreement III to the Loan Agreement Agreement March 23, 2018 This Supplemental Agreement III to the Loan Agreement (hereinafter referred to as the Party A: iKang Health Technology Group Co., Ltd. Borrower Registered address: Room 3E-2398, 3/F, No. 2123 Pudong Avenue, China (Shanghai) Pilot Free Trade Zone Party B: AVIC Trust Co., Ltd. Lender Registered address: 24/F&25/F, CATIC
Webplus: KANG/20180810/20-F/10_EX-8.1/000.htm SEC Original: a18-17215_1ex8d1.htm
List of Subsidiaries Subsidiaries Place of Incorporation iKang Guobin Healthcare Group, Inc. British Virgin Islands iKang Zhejiang, Inc. British Virgin Islands iKang MRI Center, Inc. British Virgin Islands iKang mHealth, Inc. British Virgin Islands Yuanhua Healthcare Limited Hong Kong MediFast (Hong Kong) Limited Hong Kong
Webplus: KANG/20180810/20-F/11_EX-12.1/000.htm SEC Original: a18-17215_1ex12d1.htm
I, Lee Ligang Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
Webplus: KANG/20180810/20-F/12_EX-12.2/000.htm SEC Original: a18-17215_1ex12d2.htm
Certification by the Principal Financial Officer I, Yang Chen, certify that: 1. I have reviewed this annual report on Form 20-F of iKang Healthcare Group, Inc. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light
Webplus: KANG/20180810/20-F/13_EX-13.1/000.htm SEC Original: a18-17215_1ex13d1.htm
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. August 10, 2018 EX-13.1 13 a18-17215_1ex13d1.htm EX-13.1
Webplus: KANG/20180810/20-F/14_EX-13.2/000.htm SEC Original: a18-17215_1ex13d2.htm
Certification by the Principal Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. August 10, 2018 EX-13.2 14 a18-17215_1ex13d2.htm EX-13.2
Webplus: KANG/20180810/20-F/15_EX-15.1/000.htm SEC Original: a18-17215_1ex15d1.htm
10 August, 2018 Matter No.:827098 Doc Ref: 104361926 The Directors iKang Healthcare Group, Inc. B-6F Shimao Tower 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Dear Sirs, Re: iKang Healthcare Group, Inc. (the Company) Form 20-F). Yours faithfully, Conyers EX-15.1 15 a18-17215_1ex15d1.htm EX-15.1
Webplus: KANG/20180810/20-F/16_EX-15.2/000.htm SEC Original: a18-17215_1ex15d2.htm
August 10, 2018 iKang Healthcare Group, Inc. B-6F Shimao Tower, 92A Jianguo Road Chaoyang District Beijing 100022 Peoples Republic of China Attention: The Board of Directors Dear Sirs, Re: iKang Healthcare Group, Inc. (the Company) Yours faithfully King & Wood Mallesons EX-15.2 16 a18-17215_1ex15d2.htm EX-15.2
Webplus: KANG/20180810/20-F/17_EX-15.3/000.htm SEC Original: a18-17215_1ex15d3.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Deloitte Touche Tohmatsu Certified Public Accountants LLP Beijing, August 10, 2018 EX-15.3 17 a18-17215_1ex15d3.htm EX-15.3
Company Info:
Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 20-F, Date: 2018-08-10, XBRL Interactive FinancialsCIK: 0001524190, Location: F4, SIC: 8011, SIC Desc: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Business Phone & Address:
B-6F, SHIMAO TOWER, 92A JIANGUO ROAD, CHAOYANG DISTRICT
Beijing 100022
-
- Forum
- Topics
- Posts
- Last Post
Leave A Comment
You must be logged in to post a comment.